A carregar...

Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial

BACKGROUND: High dose oral ascorbic acid substantially improved myelination and locomotor function in a Charcot-Marie-Tooth type 1A mouse model. A phase II study was warranted to investigate whether high dose ascorbic acid also has such a substantial effect on myelination in Charcot-Marie-Tooth type...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Verhamme, Camiel, de Haan, Rob J, Vermeulen, Marinus, Baas, Frank, de Visser, Marianne, van Schaik, Ivo N
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2784478/
https://ncbi.nlm.nih.gov/pubmed/19909499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-7-70
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!